Inhibition of SARS-CoV-2 Infections in Engineered Human Tissues Using Clinical-Grade Soluble Human ACE2 (2020), Monteil V. | AcademicGPT, tlooto

It is shown that clinical grade hrsACE2 reduced SARS-CoV-2 recovery from Vero cells by a factor of 1,000–5,000 and can significantly block early stages of SARS-CoV-2 infections. (2020), CELL, Monteil V. | AcademicGPT, tlooto for Academic and Research